Paolino, J., Dimitrov, B., Apsel Winger, B., Sandoval-Perez, A., Rangarajan, A. V., Ocasio-Martinez, N., Tsai, H. K., Li, Y., Robichaud, A. L., Khalid, D., Hatton, C., Gillani, R., Polonen, P., Dilig, A., Gotti, G., Kavanagh, J., Adhav, A. A., Gow, S., Tsai, J., … Pikman, Y. (2023). Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma. Clinical Cancer Research, 29(22), 4613–4626. https://doi.org/10.1158/1078-0432.ccr-22-2562

Baran, N., Lodi, A., Dhungana, Y., Herbrich, S., Collins, M., Sweeney, S., Pandey, R., Skwarska, A., Patel, S., Tremblay, M., Kuruvilla, V. M., Cavazos, A., Kaplan, M., Warmoes, M. O., Veiga, D. T., Furudate, K., Rojas-Sutterin, S., Haman, A., Gareau, Y., … Konopleva, M. (2022). Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-30396-3

Cordo’, V., Meijer, M. T., Hagelaar, R., de Goeij-de Haas, R. R., Poort, V. M., Henneman, A. A., Piersma, S. R., Pham, T. V., Oshima, K., Ferrando, A. A., Zaman, G. J. R., Jimenez, C. R., & Meijerink, J. P. P. (2022). Phosphoproteomic profiling of T cell acute lymphoblastic leukemia reveals targetable kinases and combination treatment strategies. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-28682-1

Antoszewski, M., Fournier, N., Ruiz Buendía, G. A., Lourenco, J., Liu, Y., Sugrue, T., Dubey, C., Nkosi, M., Pritchard, C. E. J., Huijbers, I. J., Segat, G. C., Alonso-Moreno, S., Serracanta, E., Belver, L., Ferrando, A. A., Ciriello, G., Weng, A. P., Koch, U., & Radtke, F. (2022). Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL. Blood, 139(16), 2483–2498. https://doi.org/10.1182/blood.2021012077